Risk assessment to guide the prevention of cervical cancer

This publication has 30 references indexed in Scilit:

• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  Published by Elsevier ,2007
• Risk of Precancer and Follow-up Management Strategies for Women With Human Papillomavirus–Negative Atypical Squamous Cells of Undetermined Significance
  Obstetrics & Gynecology, 2007
• Predicting absolute risk of CIN3 during post-colposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS)
  American Journal of Obstetrics and Gynecology, 2006
• Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
  Vaccine, 2006
• Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence
  Gynecologic Oncology, 2005
• The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
  JNCI Journal of the National Cancer Institute, 2005
• Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
  JNCI Journal of the National Cancer Institute, 2005
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
  Obstetrics & Gynecology, 2004
• A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations
  American Journal of Obstetrics and Gynecology, 2003
• Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
  JNCI Journal of the National Cancer Institute, 1989